rs1555753690
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_003072.5(SMARCA4):c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC(p.Gly237_Pro244del) variant causes a disruptive inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
SMARCA4
NM_003072.5 disruptive_inframe_deletion
NM_003072.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.66
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 4/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 4/35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 4/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 4/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 4/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 5/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 4/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 4/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.708_731delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly237_Pro244del | disruptive_inframe_deletion | 5/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.120_143delTGGCCCCGGCCCGGGTCCCGGCCC | p.Gly41_Pro48del | disruptive_inframe_deletion | 1/32 | ENSP00000496004.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 23, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 826825). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant, c.708_731del, results in the deletion of 8 amino acid(s) of the SMARCA4 protein (p.Gly237_Pro244del), but otherwise preserves the integrity of the reading frame. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 12, 2024 | The c.708_731del24 variant (also known as p.G237_P244del) is located in coding exon 3 of the SMARCA4 gene. This variant results from an in-frame deletion of 24 nucleotides at positions 708 to 731. This results in the deletion of 8 amino acids between codons 237 and 244. This in-frame variant is in a repetitive region of the gene and has no known function or association with disease. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Based on the supporting evidence, the association of this alteration with Coffin-Siris syndrome is unknown; however, the association of this alteration with rhabdoid tumor predisposition syndrome is unlikely. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at